Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
orally) improves survival compare to placebo
2013 Dec 24
11b-octadecahydro-3'H-spiro[benzo[a]fluorene-9
doi: 1158/1535-7163
OSU-03012 60331 orally) improves survival compare toOSU03012; also known as AR12, is an orally available, targeted anti cancer agent that has been shown in pre clinical studies to inhibit PDK 1, a protein in the PI3K Akt pathway that is involved in the growth and proliferation of cells, including cancer cells. AR 12 may also cause cell death through the induction of stress in the endoplasmic reticulum. We are currently conducting a multi centered Phase I clinical study of AR 12 in adult patients with
US$ 135.00
US$ 4805.80
US$ 539.89
US$ 61.23
US$ 2040.34